(Q78426368)
Statements
Anti-CD20 chimeric monoclonal antibody (rituximab) for the treatment of recalcitrant, life-threatening pemphigus vulgaris with implications in the pathogenesis of the disorder (English)
pemphigus vulgaris
1 reference
Thomas G Salopek
Sarvesh Logsetty
Edward E Tredget
1 November 2002